Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- CPRX expected to deliver increase in earnings and revenues in March 2024 quarter. - Earnings report on May 8, 2024 could impact stock price based on results. - Zacks Consensus Estimate for Q1 2024: EPS $0.34, Revenues $97.24 million. - Catalyst's Earnings ESP is +1.19%, Zacks Rank #3, indicating likely beat. - The company beat consensus EPS estimates in two of the last four quarters. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Research Analysis
- CPRX expected to deliver increase in earnings and revenues in March 2024 quarter.
- Earnings report on May 8, 2024 could impact stock price based on results.
- Zacks Consensus Estimate for Q1 2024: EPS $0.34, Revenues $97.24 million.
- Catalyst's Earnings ESP is +1.19%, Zacks Rank #3, indicating likely beat.
- The company beat consensus EPS estimates in two of the last four quarters.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.